Use of Sotatercept in France since Its Availability in June 2024: A Nationwide Study from the French Health Data System (SNDS). (PubMed, Drugs Real World Outcomes) - Sep 15, 2026 - "These findings provide the first real-world, nationwide insights into sotatercept use in routine clinical practice, showing treatment patterns broadly consistent with initial recommendations, including maintenance of background therapy and adherence to the recommended dosing interval. Further studies are warranted to assess the long-term effectiveness and safety of sotatercept."
Journal • Cardiovascular • Hypertension • Pulmonary Arterial Hypertension • Pulmonary Disease • Respiratory Diseases • Transplantation
|
|
Alain Weill; Jérémie Botton; Mahmoud Zureik; Nadia Haddy; Nazoiri Charifa
|